Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) and YS Biopharma (NASDAQ:YS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership. Analyst Ratings This is a summary of […]
Tucatinib Combo May Benefit Advanced HER2-Positive Breast Cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Atossa Therapeutics (ATOS) Appoints Jonathan Finn to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) will be issuing its quarterly earnings data on Monday, November 6th. Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) last posted its quarterly earnings results on Monday, August 14th. The company reported ($0.06) EPS for the quarter, hitting analysts’ consensus estimates of ($0.06). On average, analysts expect Atossa Therapeutics […]